Anxiety in ASD Sample Clauses

Anxiety in ASD. While anxiety does not involve in the phenomenological features of ASD; it is highly common in children and adolescents with XXX (Xxxxx et al., 2018; Xxxxxxx et al., 2015; Xxxxxxxx et al., 2008). That is, when compared to peers in the general population, anxiety problems are more prevalent in individuals with ASD (Xxxxxxx, 2004; Xxxxxxxx- Xxxxxxxxx, Xxxxx, XxXxxxxxx, & Xxxxxxx, 2010; Xxxx et al., 2018). The prevalence rate of clinically elevated anxiety problems in children who have had a statement for special educational needs or with ASD is around 42% (Xxxxxxxx et al., 2008), whilst in a community sample of children with ASD, the prevalence rate was around 79% (Xxxxxxx et al., 2015). A meta-analytic study also suggested that between 11% and 84% of children with ASD experience some degree of anxiety traits (Xxxxx, Xxxxxx, Xxxxxxxxx, & Xxxxxxx, 2009). Moreover, children and adolescents with ASD, regardless of their other co-occurring psychiatric conditions and IQ levels were found to have some degree of threshold and sub-threshold anxiety traits (Xxxxxxx et al., 2013; Xxxxxxxxx, Creemers, Vermulst, & Xxxxxx, 2018). Similar to ASD symptoms, anxiety traits are moderately heritable (~ 50 %; Xxxxxxx, Xxxxxx, & Xxxxx, 2009; Xxxxxxx et al., 2014) and there are higher levels of anxiety traits in unaffected co-twins of ASD probands (Xxxxxxx, Xxxxxx, et al., 2013). The presentation of anxiety in ASD can be complicated. The interplay between underlying mechanisms of both conditions may result in traditional and/or ASD-specific phenotypes (Xxxxx et al., 2014). Nevertheless, concurrent anxiety problems are additional burdens in daily life, they can influence social and adaptive functioning of children with XXX (Xxxxxxx, 2004).
AutoNDA by SimpleDocs

Related to Anxiety in ASD

  • Polygraph Examinations No employee shall be compelled to submit to a polygraph examination against his/her will. No disciplinary action or other recrimination shall be taken against an employee refusing to submit to a polygraph examination, nor shall any comment be entered anywhere in the investigator’s notes or anywhere else that the employee refused to take a polygraph examination, nor shall any testimony or evidence be admissible at a subsequent hearing, trial, or proceeding, judicial or administrative, to the effect that the employee refused to take a polygraph examination.

  • TRADE CONTROL COMPLIANCE a. The Parties shall comply with all export and import laws, regulations, decrees, orders, and policies of the United States Government and the Government of any country in which the Parties conduct business pursuant to this Contract, including but not limited to the Export Administration Regulations (“EAR”) of the U.S. Department of Commerce, the International Traffic in Arms Regulations (“ITAR”) of the U.S. Department of State, the U.S. Customs & Border Protection Regulations, the Harmonized Tariff Schedule, and the antiboycott and embargo regulations and guidelines as set forth in the EAR and in the U.S. Department of the Treasury, Office of Foreign Assets Control (collectively, “Trade Control Laws”).

  • Polygraph Examination No employee shall be compelled to submit to a polygraph examination. No disciplinary action whatsoever shall be taken against an employee refusing to submit to a polygraph examination; nor shall any comment be anywhere recorded indicating that an employee offered to take, took or refused to take a polygraph examination unless otherwise agreed to in writing by the parties; nor shall any testimony or evidence of any kind regarding an employee's offer to take, refusal to take, or the results of a polygraph examination be admissible in any proceeding pursuant to this Agreement, unless otherwise agreed to in writing by the parties.

  • Trade Controls DXC and Supplier will comply with all applicable export, import and trade-related laws and regulations of the United States and other nations. To this effect, Supplier warrants that: (i) if necessary and upon DXC’s request, it will provide DXC with technical specifications concerning commodities, software, technology or services covered by this agreement sufficient for DXC to determine the appropriate export and import classification of such items under applicable regulations; (ii) to the best of the Supplier’s knowledge, the Supplier is not listed on any U.S. Government international trade sanctions lists and that Supplier will give immediate notice to DXC in the event that it is so listed; and

  • Health and Safety Representative Meetings 13.1 A health and safety representative will be allowed reasonable paid time during working hours to attend occupational health and safety matters, including meetings affecting employees they represent, providing that the Representative informs their manager.

  • Child Safety Never leave a child unsupervised near a pool, not even for a second. During social gatherings at or near the pool, appoint a designated adult to protect young children from pool accidents. Children must be watched closely while swimming. Do not use floatation devices as a substitute for supervision. Toys can entice young children into the pool area. When not in use, clear the pool area of all toys.

  • Medical Examinations An employee may be required by the Employer, at the request of and at the expense of the Employer, to take a medical examination by a physician of the employee's choice. Employees may be required to take skin tests, x-ray examination, vaccination, inoculation and other immunization (with the exception of a rubella vaccination when the employee is of the opinion that a pregnancy is possible), unless the employee's physician has advised in writing that such a procedure may have an adverse affect on the employee's health.

  • Health and Safety Training Regular employees and auxiliary employees in posted positions shall participate in a Health and Safety Training session once in a calendar year. The training program offered by the Employer must be approved by the joint Health and Safety Committee prior to such training commencing. Training will be provided during normal work hours and employees shall suffer no loss of pay or benefits.

  • Inventory Management The Subrecipient must submit an annual statement identifying the status of all equipment and non-real property items purchased with ESG funds by the contract termination date. The status report should inventory all equipment and non-real properties purchased with ESG funds and state the condition of the equipment and its location.

  • Health Examinations The Employer shall provide at no cost to the employee, such medical tests, health examinations and surveillance/monitoring as may be required as a condition of employment and/or as a result of regulated hazards encountered after employment.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!